Metabolic Profiles of the Gut Microbiota in Patients with Different Stages of Metabolism Dysfunction-Associated Fatty Liver Disease
Aim: to study the metabolic activity of the intestinal microbiota depending on the stage of metabolic dysfunction-associated fatty liver disease (MAFLD). Materials and methods. The study included 85 patients with MAFLD (27 patients with steatosis without steatohepatitis and fibrosis, 42 patients w...
Saved in:
| Main Authors: | X. Cao, O. Yu. Zolnikova, R. V. Maslennikov, E. A. Poluektova, E. L. Bueverova, M. S. Reshetova, M. S. Zharkova, V. T. Ivashkin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2024-10-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/977 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut microbiota and metabolomics in metabolic dysfunction-associated fatty liver disease: interaction, mechanism, and therapeutic value
by: Luyu Wang, et al.
Published: (2025-07-01) -
Neutrophil-to-Lymphocyte Ratio as a Microbiota-Dependent Indicator of Immune Dysfunction and a Long-Term Prognostic Factor in Patients with Cirrhosis
by: E. K. Tsvetaeva, et al.
Published: (2025-08-01) -
Tryptophan Metabolites in the Progression of Liver Diseases
by: Maria Reshetova, et al.
Published: (2024-11-01) -
Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease
by: Rachmad Anres Dongoran, et al.
Published: (2023-01-01) -
Unravelling the gut-liver axis: The role of gut microbiota-mitochondria interactions in the pathogenesis and management of metabolic-associated fatty liver disease (MAFLD)
by: Binzhi Zhang, et al.
Published: (2025-03-01)